• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600

    11/22/21 6:01:00 PM ET
    $EBS
    $SITM
    $SPGI
    $UFS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $EBS alert in real time by email

    NEW YORK, Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: SITM) will replace Emergent BioSolutions Inc. (NYSE:EBS) in the S&P MidCap 400, and Emergent BioSolutions will replace Domtar Corp. (NYSE:UFS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, November 30. Paper Excellence B.V. is acquiring Domtar in a deal expected to be completed soon pending final conditions. Emergent BioSolutions is more representative of the small-cap market space.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Nov 30, 2021

    S&P MidCap 400

    Addition

    SiTime

    SITM

    Information Technology



    S&P MidCap 400

    Deletion

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Addition

    Emergent BioSolutions

    EBS

    Health Care



    S&P SmallCap 600

    Deletion

    Domtar

    UFS

    Materials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected]

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/sitime-set-to-join-sp-midcap-400-emergent-biosolutions-to-join-sp-smallcap-600-301430362.html

    SOURCE S&P Dow Jones Indices

    Get the next $EBS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EBS
    $SITM
    $SPGI
    $UFS

    CompanyDatePrice TargetRatingAnalyst
    S&P Global Inc.
    $SPGI
    2/17/2026$575.00Buy
    BofA Securities
    SiTime Corporation
    $SITM
    1/15/2026Underweight → Equal Weight
    Barclays
    SiTime Corporation
    $SITM
    12/15/2025$420.00Buy
    Goldman
    SiTime Corporation
    $SITM
    11/21/2025$350.00Buy
    Loop Capital
    S&P Global Inc.
    $SPGI
    10/1/2025$540.00Buy
    Seaport Research Partners
    SiTime Corporation
    $SITM
    8/14/2025$260.00Buy
    UBS
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    More analyst ratings

    $EBS
    $SITM
    $SPGI
    $UFS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on S&P Global with a new price target

    BofA Securities resumed coverage of S&P Global with a rating of Buy and set a new price target of $575.00

    2/17/26 7:30:15 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SiTime upgraded by Barclays

    Barclays upgraded SiTime from Underweight to Equal Weight

    1/15/26 8:30:58 AM ET
    $SITM
    Semiconductors
    Technology

    Goldman initiated coverage on SiTime with a new price target

    Goldman initiated coverage of SiTime with a rating of Buy and set a new price target of $420.00

    12/15/25 10:01:13 AM ET
    $SITM
    Semiconductors
    Technology

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EVP, Chief Financial Officer Lindahl Richard S

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/6/26 8:50:53 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Papa Joseph C covered exercise/tax liability with 37,055 shares, decreasing direct ownership by 11% to 305,445 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/5/26 9:40:29 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fowler John D Jr was granted 5,006 shares (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/5/26 9:38:11 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    SEC Filings

    View All

    Emergent BioSolutions Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Emergent BioSolutions Inc. (0001367644) (Filer)

    3/3/26 8:28:02 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Emergent BioSolutions Inc. (0001367644) (Filer)

    2/26/26 4:08:12 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by SiTime Corporation

    S-8 - SITIME Corp (0001451809) (Filer)

    2/11/26 4:25:53 PM ET
    $SITM
    Semiconductors
    Technology

    $EBS
    $SITM
    $SPGI
    $UFS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Joly Hubert bought $997,459 worth of shares (2,500 units at $398.98), increasing direct ownership by 1,515% to 2,665 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    2/12/26 4:01:28 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    President, S&P Global Mobility Eager William W bought $11,917 worth of shares (23 units at $517.58), increasing direct ownership by 0.26% to 8,724 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    1/15/26 4:01:18 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    5/15/25 4:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EBS
    $SITM
    $SPGI
    $UFS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

    TORONTO, March 6, 2026 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes in the S&P/TSX Composite Index prior to the open of trading on Monday, March 23, 2026: S&P/TSX COMPOSITE INDEX – March 23, 2026COMPANYGICS SECTORGICS SUB-INDUSTRYADDEDAbraSilver Resource Corp. (TSX:ABRA)MaterialsDiversified Metals & MiningADDEDAvino Silver & Gold Mines Ltd. (TSX:ASM)MaterialsPrecious Metals & MineralsADDEDi-80 Gold Corp. (TSX:IAU)MaterialsGoldADDEDMontage Gold Corp. (TSX:MAU)MaterialsGoldADDEDAmericas Gold and Silver Corporation (TSX:USA)MaterialsDiversified Metals & MiningFor more information about S&P Dow Jones Indices, please visit www.spdji.comABOUT S

    3/6/26 5:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    US Secretary of the Interior Doug Burgum to Address CERAWeek by S&P Global in Houston, March 23-27

    World's preeminent energy conference to focus on 'Convergence and Competition: Energy, Technology and Geopolitics.' Learn more at www.ceraweek.comHOUSTON, March 5, 2026 /PRNewswire/ -- Chairman of the National Energy Dominance Council and Secretary of the Interior Doug Burgum will deliver a plenary address to delegates at the 44th annual CERAWeek by S&P Global, March 23-27 in Houston. He will join the world's energy industry leaders, experts, government officials and policymakers, as well as leaders from the technology, financial and industrial communities addressing this year's conference.

    3/5/26 2:27:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025. Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of

    2/12/26 9:02:20 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    S&P Global Reports Fourth Quarter and Full-Year 2025 Results

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today reported fourth quarter and full-year 2025 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings.  Supplemental Information/Conference Call/Webcast Details:  The Company's senior management will review the fourth quarter and full-year 2025 earnings results on a conference call scheduled for today, February 10, at 8:30 a.m. ET. Additional information presented on the conference call, and the Company's supplemental slide content may b

    2/10/26 7:22:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

    GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of leadership experience across the healthcare and financial services sectors. He will serve on the Audit and Finance Committee. "We're pleased to welcome John to the board of directors at this important point in the company's ongoing turnaround and transformation," said Dr. Zsolt Harsanyi, Ph.D., chairman of the board. "John's deep experience in healthcare and financial markets will provide valuable insight as the company continues to execute against i

    3/3/26 8:00:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    S&P Global Appoints Chief Strategy Officer for Mobility Global Completing New Executive Leadership Team

    Martin Metzker to lead Strategy, Communications and Enterprise Marketing for Mobility Global in preparation for its planned separation into a standalone public companyNEW YORK, Feb. 19, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced the appointment of Martin Metzker as Chief Strategy Officer of S&P Global Mobility ("Mobility Global"), effective immediately. Mr. Metzker will be responsible for leading Mobility Global's Strategy function and overseeing Communications and Enterprise marketing for the business as it prepares for its planned separation from S&P Global into a standalone public company. Mr. Metzker joins the company from Boston Consulting Group, and will report to Bil

    2/19/26 4:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $EBS
    $SITM
    $SPGI
    $UFS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Emergent BioSolutions Inc.

    SC 13G - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/13/24 4:00:18 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiTime Corporation

    SC 13G/A - SITIME Corp (0001451809) (Subject)

    11/12/24 10:34:18 AM ET
    $SITM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Emergent BioSolutions Inc.

    SC 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/8/24 5:23:28 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care